Early research (Phase 1)Study completedNCT01048580What this trial is testingStudy of Perifosine + Capecitabine for Colon Cancer PatientsWho this might be right forColon Cancer AEterna Zentaris 10
Testing effectiveness (Phase 2)Study completedNCT02387996What this trial is testingNivolumab in Participants With Metastatic or Unresectable Bladder CancerWho this might be right forVarious Advanced Cancer Bristol-Myers Squibb 270
Testing effectiveness (Phase 2)Ended earlyNCT00900562What this trial is testingClinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic ChemotherapyWho this might be right forUterine Cervical CancerEndometrial Cancer PharmaMar 19
Early research (Phase 1)Study completedNCT01692262What this trial is testingInvestigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.Who this might be right forMetastatic Castrate-Resistant Prostate Cancer (mCRPC),Efficacy,Safety and Tolerability,+3 more AstraZeneca 59
Early research (Phase 1)Ended earlyNCT05338346What this trial is testingATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological MalignanciesWho this might be right forAdvanced Solid TumorsHematological Malignancies Antengene Discovery Limited 22
Early research (Phase 1)Study completedNCT03411915What this trial is testingXmAb®18087 in Subjects With NET and GISTWho this might be right forNeuroendocrine TumorGastrointestinal Neoplasm Xencor, Inc. 62
Testing effectiveness (Phase 2)Ended earlyNCT01285635What this trial is testingAT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and NeckWho this might be right forSquamous Cell Carcinoma of the Head and Neck (SCCHN) University of Michigan Rogel Cancer Center 35
Early research (Phase 1)Study completedNCT02526017What this trial is testingStudy of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced CancersWho this might be right forAdvanced Solid TumorsHead and Neck CancerPancreatic Cancer+4 more Five Prime Therapeutics, Inc. 313
Not applicableUnknownNCT06378840What this trial is testingThe Predictive Value of Immune Cell in Locally Advanced Cervical CancerWho this might be right forLocally Advanced Cervical CarcinomaConcurrent ChemoradiotherapyImmunotherapy RenJi Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT00359450What this trial is testingStudy of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)Who this might be right forNon-small Cell Lung Cancer Bristol-Myers Squibb 186
Testing effectiveness (Phase 2)Study completedNCT00165191What this trial is testingDoxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or EsophagusWho this might be right forAdenocarcinoma of StomachAdenocarcinoma of GE JunctionAdenocarcinoma of Esophagus Dana-Farber Cancer Institute 32
Early research (Phase 1)Study completedNCT01554410What this trial is testingIntensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical CarcinomaWho this might be right forCervical Carcinoma University of California, San Diego 35
Not applicableStudy completedNCT01697982What this trial is testingPilot Study of Living With Hope ProgramWho this might be right forQuality of Life University of Alberta 19
Early research (Phase 1)Study completedNCT00674024What this trial is testingPazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver FunctionWho this might be right forNeoplasmsLymphoma National Cancer Institute (NCI) 8
Early research (Phase 1)Study completedNCT01524224What this trial is testingA Dose-Escalation Study in Participants With Advanced CancerWho this might be right forAdvanced Cancer Eli Lilly and Company 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT03838159What this trial is testingNADIM II: Neo-Adjuvant ImmunotherapyWho this might be right forNon Small Cell Lung Cancer Fundación GECP 90
Testing effectiveness (Phase 2)UnknownNCT04524208What this trial is testingA Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3Who this might be right forNeuroendocrine TumorsNeuroendocrine Carcinoma Karsten Gavenis 45
Not applicableUnknownNCT05233540What this trial is testingCirculating Biomarkers in Patients With Anal Cancer Treated With Induction ChemotherapyWho this might be right forAnal CancerLocally Advanced Squamous Cell CarcinomaOligometastatic Disease+2 more Aarhus University Hospital 60
Not applicableUnknownNCT02904850What this trial is testingValidation of a Kinetic Model of ErlotinibWho this might be right forLung Cancer University Hospital, Strasbourg, France 50
Not applicableStudy completedNCT02080650What this trial is testingCharacterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)Who this might be right forProstate CancerRenal Cell CarcinomaBladder Cancer+5 more Duke University 62